Expert opinion on the treatment of patients with chronic hepatitis C

The current preferred treatment for patients with hepatitis C virus (HCV) is combination therapy consisting of pegylated interferon alfa and ribavirin (RBV) for 24–48 weeks. Although this approach appears to be highly effective for patients with HCV genotypes 2 or 3, who have a sustained virological...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Zeuzem, S, Berg, T, Moeller, B, Hinrichsen, H, Mauss, S, Wedemeyer, H, Sarrazin, C, Hueppe, D, Zehnter, E, Manns, M P
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2009
Teme:
Review Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2759987/
https://ncbi.nlm.nih.gov/pubmed/18761607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2893.2008.01012.x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki